ChemoMetec A/S Stock

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen 10:59:42 2024-04-26 am EDT 5-day change 1st Jan Change
286.6 DKK +1.49% Intraday chart for ChemoMetec A/S +0.49% -26.13%
Sales 2024 * 404M 57.86M Sales 2025 * 471M 67.5M Capitalization 4.99B 715M
Net income 2024 * 134M 19.22M Net income 2025 * 157M 22.51M EV / Sales 2024 * 11.5 x
Net cash position 2024 * 343M 49.18M Net cash position 2025 * 403M 57.86M EV / Sales 2025 * 9.74 x
P/E ratio 2024 *
37.2 x
P/E ratio 2025 *
31.8 x
Employees 171
Yield 2024 *
2.27%
Yield 2025 *
2.79%
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.49%
1 week+0.49%
Current month-32.37%
1 month-31.79%
3 months-30.17%
6 months+9.14%
Current year-26.13%
More quotes
1 week
281.20
Extreme 281.2
294.80
1 month
281.20
Extreme 281.2
422.00
Current year
281.20
Extreme 281.2
554.00
1 year
255.00
Extreme 255
554.00
3 years
255.00
Extreme 255
1 149.00
5 years
134.00
Extreme 134
1 149.00
10 years
3.26
Extreme 3.26
1 149.00
More quotes
Managers TitleAgeSince
Founder 65 96-12-31
Director of Finance/CFO - 22-10-31
Chief Tech/Sci/R&D Officer - 07-08-31
Members of the board TitleAgeSince
Director/Board Member 62 14-09-30
Founder 65 96-12-31
Director/Board Member 48 -
More insiders
Date Price Change Volume
24-04-26 286.6 +1.49% 54,112
24-04-25 282.4 -0.77% 51,280
24-04-24 284.6 -2.27% 86,448
24-04-23 291.2 +1.68% 78,112
24-04-22 286.4 +0.42% 65,122

Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 10:59 am EDT

More quotes
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
286.6 DKK
Average target price
462.5 DKK
Spread / Average Target
+61.37%
Consensus